Hull Hans

CIK 00016148762 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001614876

Recent Transactions

50 trades

Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2025-01-23+80,300→ 80,300 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-23+40,150→ 251,708 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-17$11.20/sh−15,936→ 211,558 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-10$11.56/sh−9,900→ 227,494 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-09+19,337→ 237,394 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2024-01-23+63,000→ 63,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-23+31,500→ 216,569 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-17$17.23/sh−9,786→ 185,069 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-08-04$2.08/sh+8,791→ 214,905 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2023-08-04−8,791→ 31,367 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-08-04$20.01/sh−20,050→ 194,855 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-08-03$20.00/sh−13,069→ 206,114 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-08-03$20.00/sh+1,800→ 206,114 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-08-03$2.08/sh+1,800→ 207,914 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2023-08-03−1,800→ 40,158 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-17$18.01/sh−17,937→ 219,183 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-14+35,156→ 237,120 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-30$26.52/sh−9,036→ 201,964 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-29+17,578→ 211,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-25+76,200→ 76,200 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-25+54,000→ 192,191 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-20$19.10/sh−8,748→ 138,191 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-19+17,578→ 146,939 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-01-26+112,500→ 112,500 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-05-26−4,500→ 12,979 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2021-05-26$2.08/sh+4,500→ 125,246 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-01-23+62,250→ 62,250 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-30$2.08/sh+3,500→ 120,746 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-12-30−3,500→ 17,479 total
Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-06-05+5,079→ 117,246 total
Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Series B Preferred Stock
2020-06-05−36,319→ 0 total
Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-06-05+3,821→ 3,821 total
Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Series C Preferred Stock
2020-06-05−27,322→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-03-31+70,352→ 70,352 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Series C Preferred Stock
2020-02-28$13.08/sh+27,322→ 27,322 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2015-08-21+117,590→ 137,210 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2015-06-12−8,300→ 12,200 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2015-06-12$0.19/sh+8,300→ 19,620 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2015-06-04−2,000→ 20,500 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2015-06-04$0.19/sh+2,000→ 13,320 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2015-06-04$37.64/sh−2,000→ 11,320 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2015-05-04$0.19/sh+5,000→ 16,320 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2015-05-04$30.87/sh−5,000→ 11,320 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2015-05-04−5,000→ 22,500 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2015-04-21+23,000→ 23,000 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2015-04-21+8,000→ 11,320 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2015-04-07$38.59/sh−26,613→ 4,207 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2015-04-07$39.06/sh−887→ 3,320 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2015-04-07−27,500→ 27,500 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2015-04-07$0.19/sh+27,500→ 30,820 total

Companies

Recent Filings

Address

C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A

MENLO PARK, CA, 94025

View on SEC.gov